source
- STAT+: When the path to good AI is littered with bad dataIn this edition of AI Prognosis, Brittany Trang raises the question: What kind of health data would we need to train AI models to be useful in health care.STAT · 3mo ago↗ source
- GSK goes to China for $1B siRNA deal in Arrowhead's obesity laneGSK is further delving into the cardiometabolic space — and deepening its relationship with China biotechs — in a $1 billion biobucks deal with an siRNA startup. The UK pharma is teaming with Suzho…Endpoints · 3mo ago↗ source
- STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceVivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech newsSTAT · 3mo ago